View Cart  

April 23, 2014

Vol. 11 No. 80

View Archived Issues

Sign Up Now

Intuitive Surgical Gets FDA Clearance for da Vinci Sp

Actual commercialization of the system in the U.S. won’t happen until late next year, Intuitive says. Read More

EndoStim’s LES Stimulation System Gets CE Mark for MRI Use

The company says that this clearance paves the way for acid reflux patients to receive head and extremity MRI scans. Read More

Cochlear Corporation Nabs FDA Approval of the Cochlear Nucleus

Cochlear announced that the FDA has approved the Aqua+ accessory, the only waterproof behind-the-ear solution for cochlear implant recipients on the market today. Read More

Endo Health Warned By FDA on AMS Pelvic Mesh Plant

Endo Health Solutions said the FDA warned it about procedural violations at a Minnesota plant run by its American Medical Systems subsidiary that makes pelvic mesh products. Read More

Mainstay Medical Plans IPO to Fund Back Pain Device

Mainstay Medical, an Irish back pain device company with Minnesota roots, plans to raise up to $41.9 million in an IPO on Euronext Paris. Read More

False-Positive Mammograms Have Limited Effect on Anxiety

Women whose mammograms suggest possible breast cancer that is eventually ruled out experience slightly increased anxiety, but that doesn’t necessarily affect their overall health, according to a new study. Read More

Health Scan: Radio Wave Treatment Instead of Surgery for Barrett Esophagus

Sufferers of a condition called Barrett esophagus, in which there is an abnormal change in cells lining the lower part of the esophagus due to chronic acid reflux, are usually treated with surgery. Read More

Aesthetic Medical Devicemaker Ulthera Files for an $86 Million IPO

Ulthera, which sells ultrasound energy systems for the non-invasive lifting of eyebrows and skin around the neck, filed on Monday with the SEC to raise up to $86 million in an initial public offering. Read More